SYSCHEM (INDIA)
Back to Balance Sheet
|
SYSCHEM (INDIA) Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1.53 Cr | ₹9.35 Cr | ₹25 Cr | ₹23 Cr | ₹26 Cr |
What is the latest Total Non-Current Liabilities ratio of SYSCHEM (INDIA) ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹1.53 Cr |
| Mar2024 | ₹9.35 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | ₹23 Cr |
| Mar2021 | ₹26 Cr |
How is Total Non-Current Liabilities of SYSCHEM (INDIA) Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.53 Cr | -83.70 | |
| Mar2024 | ₹9.35 Cr | -62.79 | |
| Mar2023 | ₹25 Cr | 7.46 | |
| Mar2022 | ₹23 Cr | -8.93 | |
| Mar2021 | ₹26 Cr | - | |
Compare Total Non-Current Liabilities of peers of SYSCHEM (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYSCHEM (INDIA) | ₹211.4 Cr | -2.2% | 3.7% | 11% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
SYSCHEM (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYSCHEM (INDIA) | -2.2% |
3.7% |
11% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses